104 SLE autoantibodies to casein kinase II: potential mediators of immunopathology

• Joan T Merrill,
• Philip L Cohen,
• Daniel H Shu

Affiliations

Joan T Merrill

4 Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA

Philip L Cohen

3Department of Medicine, Temple University, Philadelphia, Pennsylvania, USA

Daniel H Shu

1Lewis Katz School of Medicine at Temple University